Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1446194 BALA CYNWYD, PA
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,039,282
-$4,955,236 QoQ
Shares Held
180,871
-65.5% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#75
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Derivatives in RARE

reported options exposure · as of Jun 30, 2026
CallValue
$9,215,640
CallShares
276,000
PutValue
$16,995,510
PutShares
509,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. RARE ranks #40 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in RARE

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,215,640 276,000
2026-06-30 $6,039,282 180,871
2026-06-30 $16,995,510 509,000
2026-03-31 $5,109,705 243,900
2026-03-31 $10,994,518 524,798
2026-03-31 $7,690,745 367,100
2025-12-31 $11,433,300 497,100
2025-12-31 $14,519,900 631,300
2025-12-31 $3,503,268 152,316
2025-09-30 $7,042,510 234,126
2025-09-30 $9,276,672 308,400
2025-09-30 $8,891,648 295,600
2025-06-30 $18,379,980 505,500
2025-06-30 $2,916,908 80,223
2025-06-30 $16,856,496 463,600
2025-03-31 $4,361,856 120,460
2025-03-31 $4,008,447 110,700
2025-03-31 $6,615,567 182,700
2024-12-31 $4,413,143 104,900
2024-12-31 $13,121,633 311,900
2024-12-31 $7,590,479 180,425
2024-09-30 $10,798,920 194,400
2024-09-30 $6,684,720 120,337
2024-09-30 $10,037,885 180,700
2024-06-30 $1,022,198 24,871
2024-06-30 $6,802,050 165,500
2024-06-30 $4,068,900 99,000
2024-03-31 $6,321,826 135,400
2024-03-31 $6,158,411 131,900
2024-03-31 $2,285,474 48,950
2023-12-31 $8,464,140 177,000
2023-12-31 $5,331,930 111,500
2023-12-31 $1,699,570 35,541
2023-09-30 $4,529,580 127,057
2023-09-30 $8,320,710 233,400
2023-09-30 $8,085,420 226,800
2023-06-30 $5,104,928 110,664
2023-06-30 $7,274,701 157,700
2023-06-30 $4,414,641 95,700
2023-03-31 $3,171,910 79,100
2023-03-31 $3,103,740 77,400
2023-03-31 $2,915,791 72,713
2022-12-31 $6,110,927 131,900
2022-12-31 $5,462,307 117,900
2022-12-31 $666,642 14,389
2022-09-30 $3,796,841 91,689
2022-09-30 $3,789,015 91,500
2022-09-30 $3,867,694 93,400
2022-06-30 $1,688,378 28,300
2022-06-30 $1,294,622 21,700